Stem cell treatment for children with Alport syndrome
Treatments studied
Part of Genetic & congenital, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study tests if stem cells from umbilical cord blood can help children aged 3 to 12 with Alport syndrome, a genetic kidney disease. It aims to slow kidney damage and improve function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 12 years old
- You have been diagnosed with Alport syndrome
- Your kidneys are still working well (stage 1 to 3 chronic kidney disease)
- You have protein in your urine (or blood in urine)
- You are generally healthy (no serious infections, allergies, or other major organ problems)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a medicine called an ACE inhibitor (a type of blood pressure drug) in people with early-stage Alport syndrome, a genetic kidney condition. The goal is to see if it can protect kidney function and reduce protein in urine, before kidney damage gets worse.
This study looks at how specific genetic changes (genotypes) relate to kidney problems and urine blood findings in people with Alport syndrome. It may help doctors predict disease course and tailor care, though it may not involve new treatment.
This is a registry that collects information from people with Alport syndrome to better understand the disease and how to delay kidney failure. It may help researchers learn which factors and treatments are most important over time.
This study tests whether a single infusion of stem cells from bone marrow is safe for people with chronic kidney disease (CKD). It aims to see if this treatment can help slow kidney function loss.
This study tests whether a transfusion of special cells (called mesenchymal stem cells) can help people whose lupus-related kidney disease (lupus nephritis) has not improved with standard therapy. The goal is to see if this treatment can reduce kidney inflammation and improve overall condition.
This trial tests whether stem cells from donated umbilical cords can help people with acute-on-chronic liver failure, a sudden worsening of chronic liver disease. The goal is to see if this treatment improves liver function and survival.
Hear when a new Alport Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.